ESPR 2.41 (+0%)
US29664W1053BiotechnologyBiotechnology

Esperion Therapeutics (ESPR) Stock Highlights

2.41 | +0%
2024-11-21 04:42:59
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment.

Statistics

Range Today
2.31 2.45
Volume Today 4.28M
Range 1 Year
1.15 3.4
Volume 1 Year 1.54B
Range 3 Year
0.7 10.02
Volume 3 Year 2.7B
Range 10 Year
0.7 120.96
Volume 10 Year 4.01B

Highlights

Market Capitalization 447.39M (small)
Floating Shares 194.82M
Current Price 2.41
Price To Earnings -2.27
Price To Revenue 1.85
Earnings Per Share -0.92
Payout Ratio 0%

Performance

Latest 0%
1 Month +18.14%
3 Months +27.51%
6 Months +0.84%
1 Year +100.83%
3 Years -67.78%
5 Years -94.71%
10 Years -92.1%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.